ARCHIVES

Cancer Screening Priorities Questioned In Dartmouth Study

This article is from The Cancer Letter archive.

Vol. 26 No. 3 | March 28, 2003

Download PDF Visit The Full Archive

Related Articles

Central Line Safety Intervention Lowers Patient Infection Rate

October 25, 2013

In Brief: Murphy New ACS President, Robert McKenna Named President Elect Gehan Receives Gottlief Award

November 18, 1983

FDA Grants Orphan Designation To Photofrin for Mesothelioma

December 30, 2011

NCAB working Group Is Not Subject To Open Meetings Law, NCI Official Says

December 9, 1994

Compromise on 6,000 Grants Would Make NCI Payline Around 163-164: Natcher Committee Close to Markup

June 28, 1985

FDA Committee Okays Carboplatin For Second Line Ovarian Cancer

January 6, 1989